Cardiotoxicity of Pertuzumab Containing Regimens for HER-2 Positive Breast Cancer
Class of 2017 Abstract === Objectives: Specific Aim #1: Describe the incidence and degree of severity of cardiac dysfunction in case studies, retrospective chart analyses, and prospective randomized clinical trials for patients treated with pertuzumab containing regimens for neoadjuvant treatment of...
Main Authors: | , |
---|---|
Other Authors: | |
Language: | en_US |
Published: |
The University of Arizona.
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/624205 http://arizona.openrepository.com/arizona/handle/10150/624205 |